Stem Cells May Move to the Front Line against Multiple Scler

Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.

Related Keywords

Italy , Sweden , Milan , Lombardia , Ositran , Veneto , United Kingdom , London , City Of , Uppsala , Uppsala Lan , Gavin Giovannoni , John Snowden , Basil Sharrack , Dame Pamela Shaw , Raffaella Greco , Joachim Burman , Richard Burt , Uppsala University , Sclerosis International Stem Cell , London School Of Medicine , Department Of Medical Sciences , University Of Sheffield , European Society For Blood , Uk National Institute For Health , Autoimmune Diseases Working Party , Sheffield Institute For Translational Neuroscience Sitra , Care Research , Imperial College London Paoloa Muraro , Ms Research Clinic , Northwestern University , Sheffield Institute , Translational Neuroscience , Third International Symposium , Stem Cell Treatment , Multiple Sclerosis , Marrow Transplant , Raffaele Hospital , European Society , Marrow Transplantation , Sheffield Teaching Hospitals , Treatment Algorithm , Multiple Sclerosis Disease Modifying , London School , Imperial College London , Medical Sciences , Experimental Neurology , Expanded Disability Status Scale , Autologous Stem Cell Transplantation , Relapsing Remitting Multiple Sclerosis ,